Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Harshad P. Patil"'
Autor:
Jasmine Tomar, Wouter F. Tonnis, Harshad P. Patil, Anne H. de boer, Paul Hagedoorn, Rita Vanbever, Henderik W. Frijlink, Wouter L.J. Hinrichs
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 9, Iss 6, Pp 1231-1240 (2019)
Vaccination via the pulmonary route could be an attractive alternative to parenteral administration. Research towards the best site of antigen deposition within the lungs to induce optimal immune responses has conflicting results which might be depen
Externí odkaz:
https://doaj.org/article/e79481a79611462b9c54db7a3e21991f
Autor:
Danielle Freches, Natacha Rocks, Harshad P. Patil, Fabienne Perin, Jacques Van Snick, Rita Vanbever, Didier Cataldo
Publikováno v:
International Journal of Pharmaceutics: X, Vol 1, Iss , Pp - (2019)
PEGylation is a promising approach to increase the residence time of antibody fragments in the lungs and sustain their therapeutic effects. However, concerns arise as to the potential pulmonary toxicity of antibody fragments conjugated to high molecu
Externí odkaz:
https://doaj.org/article/371a5f14a0c8448c99c1d9cb15354492
Autor:
Harshad P. Patil, José Herrera Rodriguez, Jacqueline de Vries-Idema, Tjarko Meijerhof, Henderik W. Frijlink, Wouter L. J. Hinrichs, Anke Huckriede
Publikováno v:
Vaccines, Vol 5, Iss 3, p 19 (2017)
Adjuvants are key components in vaccines, they help in reducing the required antigen dose but also modulate the phenotype of the induced immune response. We previously showed that GPI-0100, a saponin-derived adjuvant, enhances antigen-specific mucosa
Externí odkaz:
https://doaj.org/article/b6b0f2c48095449f8125a519889b7a19
Publikováno v:
Viral immunology. 35(6)
Various vaccines are under development to prevent chikungunya (CHIKV) infection. For the assessment of the CHIKV vaccine-induced antibody response, it is extremely important to understand antibody response after the infection has occurred. Previously
Autor:
Akhilesh Chandra Mishra, Sanjay Lalwani, Vidya A. Arankalle, Shubham Shrivastava, Harshad P. Patil, Suhas T. Mhaske, Sonali Palkar
Publikováno v:
Virus Genes
In view of the rapidly progressing COVID-19 pandemic, our aim was to isolate and characterize SARS-CoV-2 from Indian patients. SARS-CoV-2 was isolated from nasopharyngeal swabs collected from the two members of a family without any history of (H/O) t
Autor:
Sanjay Lalwani, Harshad P. Patil, Shubham Shrivastava, Akhilesh Chandra Mishra, Sonali Palkar, Vidya A. Arankalle, Prajakta S. Rane, Pravin Kore, Ruta Kulkarni
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 153, Iss 5, Pp 658-664 (2021)
Indian Journal of Medical Research, Vol 153, Iss 5, Pp 658-664 (2021)
Background & objectives: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) continues to be a devastating pandemic. This study was aimed at performance assessment of SARS-CoV-2 IgM and IgG ELISA
Autor:
Mrunal Gosavi, Harshad P. Patil
Publikováno v:
Vaccine. 40(34)
Currently there is no clinically approved chikungunya virus (CHIKV) vaccine for immunization. Though definite need is felt, long disappearance of CHIKV has been a concern. Inactivated CHIKV (I-CHIKV) is an attractive antigen to develop effective vacc
Autor:
Divya Tiraki, Harshad P. Patil, Ruta Kulkarni, Vidya A. Arankalle, Akhilesh Chandra Mishra, Shubham Shrivastava
Publikováno v:
Transactions of The Royal Society of Tropical Medicine and Hygiene. 114:513-520
BackgroundDengue is a public health problem worldwide. Therapeutic monoclonal antibodies (MAbs) against dengue virus (DENV) are likely to be available soon. In view of the feasibility issues pertaining to pretreatment viraemia quantitation for therap
Autor:
Rita Vanbever, Anne H. de Boer, Harshad P. Patil, Henderik W. Frijlink, Wouter L. J. Hinrichs, Paul Hagedoorn, Wouter F. Tonnis, Jasmine Tomar
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 9, Iss 6, Pp 1231-1240 (2019)
Acta Pharmaceutica Sinica B, 9(6), 1231-1240. Chinese Academy of Medical Sciences
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, (2019)
Acta Pharmaceutica Sinica B, 9(6), 1231-1240. Chinese Academy of Medical Sciences
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, (2019)
Vaccination via the pulmonary route could be an attractive alternative to parenteral administration. Research towards the best site of antigen deposition within the lungs to induce optimal immune responses has conflicting results which might be depen
Autor:
Sanjay Lalwani, Harshad P. Patil, Vidya A. Arankalle, Sonali Palkar, Akhilesh Chandra Mishra, Shubham Shrivastava, Prajakta S. Rane
Publikováno v:
Viral immunology. 34(3)
For the assessment of vaccine-induced immune response and to understand the role of antibodies in neutralization, it is necessary to assess dynamics of various antibodies in patients with different clinical manifestations. This study aims to quantita